Earnings Release • Mar 13, 2025
Earnings Release
Open in ViewerOpens in native device viewer

| Informazione Regolamentata n. 0481-26-2025 |
Data/Ora Inizio Diffusione 13 Marzo 2025 21:57:17 |
Euronext Star Milan | |||
|---|---|---|---|---|---|
| : | |||||
| Societa' | El.En. | ||||
| Identificativo Informazione Regolamentata |
: | 202400 | |||
| Utenza - Referente | : | ELENN01 - Romagnoli Enrico | |||
| Tipologia | : | 1.1; REGEM; 3.1 | |||
| Data/Ora Ricezione | : | 13 Marzo 2025 21:57:17 | |||
| Data/Ora Inizio Diffusione | : | 13 Marzo 2025 21:57:17 | |||
| Oggetto | : | The Board of Directors of El.En. Spa approves the 2024 draft financial statements |
|||
| Testo del comunicato |
Vedi allegato


1.1 3.1 REGEM
Consolidated Revenue: 565.8 million of euro, in line with the results for 2024. Consolidated Net Income: 51,6 million, up 7%.
Group Net Financial Position: Positive cash position of 110,6 million of euro. Proposed Dividend: 0,22 euro per share. 2025 Guidance: Forecast of slight revenue growth and EBIT in line with 2024
Florence, March 13, 2025 – The Board of Directors of El.En. S.p.A., a leader in the laser market and listed on the Euronext STAR Milan ("STAR") of the Italian Stock Exchange, today approved the consolidated financial report as of December 31, 2024, the separate financial statement project as of December 31, 2024, and the sustainability reporting as of December 31, 2024, to be submitted to the shareholders' meeting.
The draft financial statement has been prepared in accordance with IAS/IFRS accounting principles, reclassifying the contribution of the chinese industrial cutting division in the assets, liabilities, and income statement results from discontinued operations, both for the current year and the previous year, due to the ongoing negotiations for the sale of the division, in accordance with IFRS5.
The 2024 financial year concluded with consolidated revenue of 565,8 million of euro, a slight decline of 1,76% compared to 2023, and an income from operations result of 78,3 million of euro, exceeding the 78,2 million of the previous year and improving its incidence on revenue. The Group net income was 51,6 million of euro, marking an approximate increase of 7% compared to 48,2 million from the previous year.
Gabriele Clementi, President of El.En. S.p.A., said "Despite a complex market environment, the performance for the year was positive, and the issues encountered only marginally impacted the overall sales results, thanks to the strong solidity of the Group, which was able to improve the net income from 48,2 million of euro in 2023 to 51,6 million of euro. The decision to divest from the chinese subsidiary engaged in Laser Cutting resulted in a different accounting representation. Effective management of working capital allowed for a significant increase in the net financial position, which stands at 110,6 million of euro. The results achieved highlight the proactive

approach of management to market challenges, with strategies aimed at ensuring continuity in the excellent financial solidity of the Group."
With reference to the guidance provided by the Group for the 2024 financial year, the results align with the forecasts, both in revenue growth and in the EBIT performance for 2024.
The 2024 financial year closed confirming the trends already visible throughout the year. The medical sector recorded a positive recovery, quarter after quarter, with an overall revenue increase at the end of the year of 4,6%, and an 11,4% increase in the IV quarter compared to the same period in 2023. In contrast, the industrial sector continued to suffer due to the weakness of the Italian market, with a quarterly revenue decline of 33,1%, leading to an annual reduction of 15,3%.
The representation of the income statement according to IFRS 5 indicates the achievement of the income target of the guidance for 2024, reporting an operating result of 78,3 million of euro, higher than the 78,2 million of euro in 2023. However, including the results of the subsidiary Penta Laser Zhejiang, which is in the process of being divested, EBIT would have been 71,0 million of euro, lower than the 72,7 million of euro from the previous year.
Two unexpected events negatively impacted the income results in the fourth quarter: the worsening crisis of the Japanese subsidiary Withus generated losses and impairments, reducing the operating result by approximately 0,7 million of euro, while the unfavorable ruling against Penta Laser Zhejiang in the Baoyuan case led to an additional cost of around 2 million of euro included in the income statement line for discontinued operations, where all the losses of the company for the year 2024 are reclassified.
Revenue growth in the medical sector showed significant acceleration, reaching 4,6% year-on-year, a remarkable result considering the difficult context influenced by complex macro and microeconomic conditions in key markets such as the United States and the Middle East. Within this sector, systems sales increased across all three main segments: aesthetics, surgery, and therapy. In particular, there was a rapid increase in post-sale revenues, especially due to the expansion of sales of sterile optical fibers for surgical urology applications.
Product innovation continues to be a fundamental pillar of the Group's marketing and commercial strategy. The expansion of the range of products available for sale, along with related innovation, is the foundation of the strategy to expand our activities and sales.
The industrial sector especially suffered from difficulties in the Italian market, made uncertain by the expiration of benefits from the Industry 4.0 tax incentives program and the long wait for the operational details of the new 5.0 initiative, which were announced only in the summer of 2024.
In the industrial applications sector, a marked weakness in the Italian market was evident, with a recorded revenue decline of 39,5%, compared to an overall decline of 15,3% in the industrial sector sales. On the other hand, the strategic commitment to intensify export activities has begun to bear fruit, with significant contributions from Lasit's foreign subsidiaries in Poland, Spain, Germany, the United Kingdom, and, starting in 2025, in France. Cutlite Penta has also planned to pursue this strategy of expansion abroad, with plans for the opening of subsidiaries for the local market in Poland, Germany, and Spain in 2025. Additionally, the North American market represented a significant contribution in the industrial sector.
Throughout the year, the Group continued its sustainability initiatives, which are also included among the performance indicators for management compensation. The new five-year Sustainability Plan 2023-2027 identifies specific and measurable sustainability activities and objectives on sensitive topics such as combating climate change, circular economy, promoting a responsible supply chain, valuing people, and contributing to the community. The commitment to sustainable

development is reaffirmed, where environmental and social responsibility increasingly become an integral part of the business model.
From January 1, 2024, El.En. Group will prepare its sustainability reporting in accordance with the provisions of Legislative Decree No. 125 of September 6, 2024, which implements the European Directive CSRD 2022/2464 (Corporate Sustainability Reporting Directive). This reporting also includes the requirements set forth by Regulation 852/2020 - EU Taxonomy Regulation 2020/852.
At the end of the 2024 financial year, the net financial position stood at 110,6 million of euro, indicating a strong financial solidity of the industrial group.
In 2024, consolidated revenues of the Group recorded a slight decrease (-1,76%), mainly due to the performance of the industrial sector. As a result, the overall weight of sales in the medical sector increased, rising from 68,1% to 72,5% of the Group's total sales, highlighting the growing importance of this area compared to the industrial sector, as previously described.
In 2024, sales in the medical and aesthetic systems sector showed signs of recovery, with increases in both systems and post-sale revenues. A significant signal was the return to growth in the Aesthetics segment, driven by a very positive performance in the fourth quarter, observed in all geographic markets and across all application disciplines. In the United States, some businesses related to cellulite treatments and dental applications are undergoing reorganization. Both underperformed in 2024.
In the field of aesthetic applications, the recovery in sales was evident across all disciplines, including body contouring, remodeling and facial rejuvenation, treatment of melasma and other skin pigmentation issues, and toning with ultrafast picosecond lasers. In the fourth quarter, the group achieved a notable recovery in sales also in the hair removal sector. The general market trend showed robust demand for anti-aging applications. However, the hair removal sector, especially in the market segment covered by the technologies offered by the Group, is facing increasing competitive pressure and a general decline in demand strength.
The fastest growth was recorded in the aesthetics sector, with an increase of approximately 4,2%, reaching a revenue of about 235,5 million of euro compared to 225,9 million of euro in the previous 2023 financial year.
There was also good growth in the medical service segment, which increased by 13,5%, with revenue amounting to about 79,6 million of euro compared to 70,1 million of euro in the 2023 financial year. Thanks to the excellent performance in the fourth quarter, the Therapy segment also grew by approximately 1,7% year-on-year, exceeding the revenue results of 2023.
In the industrial sector, an overall decline of about 15,3% is recorded, with revenue standing at 155,4 million of euro compared to approximately 183,6 million of euro in the same period of the previous year. The revenue and order intake performance were weak in the first half, showing signs of recovery in the second half of the year.
In this context, there was sustained growth in revenue from post-sale services, amounting to approximately 17 million of euro, with an increase of 19,24% compared to the same period in 2023, a direct effect of the rapid increase in the number of systems installed over the last two years.
However, a decline in sales of sources is observed, while the year recorded a record in revenue for systems dedicated to art conservation, surpassing the record results of 2023.
El.En. Group donated the advanced laser system EOS 1000 LQS, designed for the precise cleaning of ancient artifacts, to celebrate the 200th anniversary of the Egyptian Museum of Turin, a global reference point for Egyptology and archaeology. The delivery ceremony marked an important

milestone in the conservation of the cultural heritage of the Turin institution. The laser system will play a crucial role in the restoration and safeguarding of the invaluable treasures of the Museum. The collaboration of El.En. with the Egyptian Museum reflects only a part of the Group's commitment to the protection of cultural heritage on a global scale.
Caption: Statue cleaned with El.En. laser, representing the seated god Ptah, from Luxor: XVIII dynasty, reign of Amenhotep III (1390-1353 BC).

From a geographical perspective, total sales were driven by Europe, with an approximate revenue increase of 9,43%, reaching about 169,1 million of euro compared to 154,5 million of euro in the same period of 2023. The Rest of the World also grew by 7,14%, recording revenue of 289,0 million of euro compared to 269,8 million of euro in 2023. In contrast, Italy saw a decline (approximately 29%), with revenues amounting to 107,7 million of euro versus 151,7 million of euro in 2023.


Gross Margin was 245,6 million of euro, an increase of 4,63% compared to approximately 234,8 million of euro as of December 31, 2023, with a recovery in sales margins from 40,8% to 43,4%. The improvement recorded was based on a favorable sales mix, characterized by an increase in sales in the medical sector, which has higher margins, amid the decline in the industrial sector. Additionally, the geographical sales mix in the industrial sector played a crucial role: while sales in the competitive Italian market decreased, exports showed an increase, generating higher average margins. This change in the sales composition, a result of a well-defined strategy, contributed to greater overall profitability.
EBITDA was approximately 91,8 million of euro, in line with 92,2 million of euro as of December 31, 2023. The incidence on revenue marginally increased (16,2% in 2024 vs 16,0% in 2023).
EBIT showed a positive balance of 78,3 million of euro, slightly up from 78,2 million of euro as of December 31, 2023, with an Ebit margin of 13,8% compared to 13,6% in the previous year.
Financial management recorded a positive net result of 802 thousand of euro, a significant increase compared to the negative result of 449 thousand of euro from last year, partly due to positive foreign exchange differences but mainly due to financial income (+1,4 million of euro) resulting from the management of cash held particularly by El.En., Deka Mela, and Quanta System.
The exit of Private Equity funds from Penta Laser Zhejiang marked the impossibility of completing the company's IPO in the Chinese market. According to the contractual clauses stipulated in 2019 for the purchase of shares in Penta Zhejiang, the listing by November 2024 was a condition for the payment of an earn out of 5 million of euro to the minority partner liquidated at the end of 2019. Consequently, the financial liability was eliminated, recognizing the related income.
The result before taxes shows a positive balance of 84,1 million of euro (compared to 77,8 million of euro in FY 2023), marking an increase of 8%.
The tax burden for the year benefited from the agreement signed by El.En. S.p.A. with the revenue agency for the renewal of the so-called Patent Box for the period 2020/2024.
The Group closed the 2024 financial year with a net income of 51,6 million of euro compared to 48,2 million of euro from the previous year. The incidence on revenue for the period was 9,1%, and the increase was 7%.
Net Financial Position: Cash generation in 2024 was robust, with the net financial position exceeding 110 million of euro at the end of the financial year. In the second half of the year, ordinary management contributed to improving the net financial position by approximately 42 million of euro. It is important to note that about 16 million of euro flowed into the net financial position due to the liquidation of financial instruments accounted for in fixed assets, completed in the first half, providing an additional contribution to that from current operations. Similarly, the net financial position benefited from the cancellation of the financial liability of 5 million of euro related to the previously mentioned earn-out clause. During the financial year, dividends of approximately 17 million of euro were distributed, while investments in fixed assets amounted to around 14 million of euro.


The net result from activities currently in the process of divestment, particularly Penta Laser Zhejiang and its Chinese subsidiaries, amounted to approximately 3,5 million of euro. Excluding the capital gain from the sale of 100% of the shares of Cutlite Penta to Ot-las, the loss was 10,4 million of euro. The operational difficulties encountered in the Group's Chinese activities were decisive in the decision to divest control of these same activities.
The company recorded revenue of over 148,1 million of euro, an increase of approximately 7,6% compared to the revenue of 137,7 million of euro in FY 2023.
EBITDA stood at 23,6 million of euro, an increase of 3,9% compared to 22,7 million of euro in the previous year, with an EBITDA Margin that decreased from 16,5% as of December 31, 2023 to 16% in the financial year under review.
Income before taxes was approximately 37,7 million of euro, an increase of 11,43% compared to 33,8 million of euro in the previous year.
The tax burden for the year benefited from the agreement signed by El.En. S.p.A. with the revenue agency for the renewal of the so-called Patent Box for the period 2020/2024.
El.En. S.p.A. closed the financial year with a net income of approximately 34 million of euro compared to 28,1 million of euro in 2023, marking a positive change of 20,86% and an incidence on revenue of about 23% compared to 20,4% in the 2023 financial year.
The Net Financial Position of El.En. S.p.A., as of December 31, 2024, was cash positive at approximately 49,1 million of euro compared to 32,2 million of euro as of December 31, 2023.
It is noted that as of December 31, 2023, the "Other non-current liabilities" included the debt for the earn-out due to the former minority partner of Penta Laser Zhejiang Co., Ltd under the 2019 share purchase agreement: this amounted to 40 million Renminbi (approximately 5 million of euro), to be paid if an IPO of Penta Laser Zhejiang Co., Ltd was conducted within 5 years of the purchase date, which occurred in November 2019.
Following the negative results achieved by Penta Laser Zhejiang, the suspension of the IPO process, and the subsequent request for the exit of private equity funds from the capital of the Chinese subsidiary, management halted the IPO process and consequently eliminated the financial liability, recognizing the related financial income in the income statement.
At the end of February 2025, the Group disposed of a 46% stake in the Japanese subsidiary Withus, thereby transferring control to the minority shareholders who co-founded the company with El.En. in 2007. The direct distribution in the Japanese territory of professional aesthetic systems produced in Italy had been interrupted for several years, and the company now mainly engages in service activities for the installed base and sales of locally sourced aesthetic products. In this context, the commercial relationship with the parent company has become of secondary importance. Following the financial crisis of Withus's main customers, the accumulated losses and the unpromising business outlook thus far have suggested leaving it to local management to relaunch Withus's activities on new foundations. Due to the residual stake held by the Group, amounting to 33%,

starting from February 2025, the consolidation of the stake in the consolidated financial statements will be conducted using the equity method.
As part of the reorganization of the laser cutting activities, the Group suspended and then halted the IPO process for the laser cutting sector, with the repurchase on August 29, 2024, by Ot-las Srl of 100% of the shares of Cutlite Penta Srl held by Penta Laser Zhejiang. Subsequently, Penta Laser Zhejiang liquidated the stakes of the involved private equity funds, returning to investors the invested capital plus an interest of 6% per annum, totaling approximately 19,4 million of euro, effectively marking the cessation of the IPO process.
To prevent possible disputes from the CITIC fund, which had waived its right of withdrawal, management opted for liquidation, paying approximately 5,7 million of euro as capital and interest.
On November 8, 2024, El.En. S.p.A. announced the execution of a framework agreement with Yangtze Optical Fibre and Cable Joint Stock Limited Company (YOFC) to negotiate the sale of the majority of the companies in the laser cutting business, including Cutlite Penta S.r.l. and Cutlite do Brasil Ltda, with a total expected value of 55,3 million of euro. Under the agreement, Ot-las S.r.l. would sell 59,18% of Penta Laser Zhejiang to YOFC in exchange for 298,7 million RMB (approximately 38,8 million of euro) and a 67% stake in Cutlite Penta S.r.l. for approximately 16,5 million of euro. YOFC would also participate in a capital increase of Cutlite Penta S.r.l. for 51,256 euro, raising its stake to 70,06%.
Following the sale provided in the framework agreement, El.En. would have retained a 19,3% stake in Penta Laser Zhejiang and a 30% stake in Cutlite Penta.
On January 2, 2025, El.En. announced that, following the agreements disclosed on November 8, it was agreed to extend negotiations until March 31, 2025, reaffirming that Cutlite Penta would remain an Italian brand. The importance of maintaining the brand identity was also emphasized, keeping Ot-las as the majority shareholder of Cutlite Penta and YOFC as a significant minority shareholder.
It is important to note that legally binding agreements will take effect only upon the signing of final contracts. The final transfer of control of the laser cutting division will be subject to the procedure required by D. Lgs. 21/2012 and subsequent amendments at the Italian Prime Minister's Office.
In December 2024, the company Cutlite Penta USA Inc. was established, wholly owned by the subsidiary BRCT Inc.
* * * * * * * * *
The manager in charge of preparing the company's accounting documents, Dr. Enrico Romagnoli declares, pursuant to paragraph 2 of article 154-bis of the Consolidated Law on Finance, that the accounting information contained in this press release corresponds to the documentary findings, books and accounting records.
* * * * * * * * *


The preparation of the Group's annual budgets revealed a reasonable optimism for the improvement of results in 2025 compared to 2024, both in terms of revenue and operating profitability. The results of the first two months of 2025 appear to confirm this confidence.
However, the outlook for the rest of the year is more complex due to the ongoing conflicts and instability in international political relations, which have led to increased caution from central banks regarding interest rate cuts, the weakening of the US dollar, and forecasts of a slowdown in the US economy.
In this very uncertain economic context, the Group anticipates revenue growth, particularly in the industrial sector, and an operating result aligned with that of 2024.
These forecasts do not take into account the impact of any potential tariffs imposed by the US administration on the Group's products destined for the medical and industrial markets, which, if significant, could negatively affect both revenue and profitability in the important US market.
The Board of Directors approved the annual financial statements and the consolidated financial statements in electronic XHTML format, including the markings according to the ESEF Regulation taxonomy, authorizing the President and the Managing Directors, also separately from each other and with a free signature, to make any minor changes.
In compliance with legal and regulatory obligations, the Board of director of El.En. S.p.A. approved the "Sustainability Report" for the fiscal year 2024, in accordance with the Decree, the ESRS reporting criteria, as well as Article 8 of the Taxonomy Regulation.
On April 29, 2024, the Shareholders' Meeting of El.En. S.p.A. authorized the purchase of its own shares, within 18 months from the date of the resolution, under the conditions proposed by the Board of Directors, in accordance with articles 2357 and 2357-ter of the Italian Civil Code. El.En. S.p.A. currently holds 45.470 of its own shares, representing 0,568% of the share capital, and this authorization will expire on October 28, 2025.
The Board decided to ask the shareholders' meeting called to approve the 2023 financial statements for a new authorization to purchase its own shares within the limits of the law, with the cancellation of the unused portion of the authorization granted on April 29, 2024.
The purchase of treasury shares, if authorized, shall be carried out for the following potential, concurrent, or alternative purposes: primarily for allocation, distribution, or in-kind payments to employees and/or collaborators and/or members of the company's administrative bodies or its subsidiaries, pursuant to incentive remuneration plans in accordance with the remuneration policy approved by the company's shareholders' meeting; on a residual basis, for exchanges or swaps of shareholdings within and on the occasion of strategic transactions.


The authorization is requested for the purchase, in one or more tranches, of a maximum number of ordinary shares, which may not exceed one-tenth of the share capital. The current subscribed and paid-up share capital of El.En. S.p.A. is 2.603.961,75. Therefore, the maximum number of shares the company could hold – representing 20% of the capital – is 16.024.380 shares with a nominal value of 520.792,35, including the shares already held by the Company (n. 45.470).
The authorization is requested for the maximum period allowed by law, of 18 months from the date of the shareholders' meeting resolution.
The purchase of own shares will be made in accordance with the principle of equal treatment of shareholders as set out in art. 132 of the Italian Legislative Decree 58/1998 and art. 144-bis of the Consob Issuers Regulation. Therefore, the administrators ask to be authorized to proceed with the purchase, through various methods to be determined for each operation: through public purchase or exchange offers, on regulated markets.
Shareholders are asked to authorize the purchase at a price that is not less than the closing price of the stock on the previous trading day, reduced by 10%, and not more than 10% above the official trading price recorded on the day before the purchase.
The board also asks to be authorized to sell, within 10 years of the resolution, the purchased shares at a price, or equivalent in the case of corporate transactions, not less than 95% of the average official trading prices recorded in the five days before the sale.
The price limits may not be respected for the disposal of own shares in ways other than selling, such as using the shares as consideration in extraordinary operations.
The acts of selling and disposing of own shares will take place without any time constraints, in one or more times even before the total amount of buyable own shares is exhausted, using any method deemed appropriate by the board and in full compliance with current European, delegated, and domestic regulations.
The shareholders' meeting is convened to elect the new Board of Statutory Auditors. The Company published on March 3 the outgoing Board of Statutory Auditors' guidance on the quantitative and qualitative composition of the new board, expressed in consideration of the results of the selfassessment process and the Company's Policy on the composition of corporate bodies.
Please note that this orientation is available at the company's headquarters, on the company's website at www.elengroup.com section Investor Relations/governance/documenti assembleari/2025, at Borsa Italiana s.p.a. (eMarket SDIR) and on the authorized storage website .
The Board of Directors has positively assessed the independence of the directors classified as independent, on the basis of the information received by the relevant directors. It also has received a positive outcome form the Board of Statutory Auditors regarding the self-assessment of said body in respect to the maintenance of independence requirements among its members.
In compliance with legal and regulatory obligations, El.En. S.p.A. has approved the "Report on the Remuneration Policy and Compensation Paid," which will be filed and published within the deadlines set by the applicable regulations.


The Board of Directors has also approved the annual report on Corporate Governance and Ownership Structure for the financial year 2024. This report will be filed and published separately from the management report in the dedicated section of the issuer's website at the specified address.
The Board of Directors resolved to call the annual Shareholder meeting for April 29th, 2025 (first call) and May 6th, 2025 (second call) and resolved to propose to distribute a dividend of 0,22 euro per share, in compliance with art. 2357-ter c.c., to be paid on May 21st, 2025, to be assigned on May 19th, 2025 (coupon no. 4) with record date May 20th, 2025.
* * * * * * * * *
On 3rd October 2012 the board of directors resolved, by opting-out as allowed by artt. 70, paragraph 8 and 71, paragraph 1-bis of the Issuers' Regulation CONSOB 11971/99, to make exceptions to make available to the public the provided informative documents in the event of significant mergers, spin-offs, share capital increase by means of the conferral of assets in kind, takeover and transfers.
* * * * * * * * *
The Annual Financial Report, including the draft statutory financial statements, the consolidated financial statements, the management report (which includes the sustainability reporting), the certifications pursuant to Article 154-bis, paragraphs 5 and 5-ter of the TUF, the report of the independent auditors, and the report of the Board of Statutory Auditors, as well as the explanatory report of the Board of Directors on the items on the agenda of the Shareholders' Meeting, the remuneration report pursuant to Article 123-ter of the TUF, and the corporate governance report, will be made available to the public at the Company's registered office, on the website www.elengroup.com, at Borsa Italiana, and through the storage mechanism within the legal deadlines.
Additionally, other necessary documents and information related to the Shareholders' Meeting will be made available on the Company's website.
* * * * * * * * *


Friday, March 14, 2025, at 2:30 PM (CET) – 1:30 PM (GMT) – 8:30 AM (EST) – there will be a Conference Call with the financial community, during which the Group's 2024 economic-financial results will be discussed. You can connect via the following link:
https://polytemshir-it.zoom.us/j/85010163469?pwd=WfStCgJpTqfRjM1Ts5DSiuyJz3Wqqv.1
ID meeting : 850 1016 3469 Access Code: 145796
Find your local number: https://polytemshir-it.zoom.us/u/kd0MVShImr
* * * * * * *
Before the conference call, you can download the presentation slides from the Investor Relations page of the EL.EN. website: http://www.elengroup.com/it/investor-relations/presentazionisocietarie
* * * * * * *
This press release may contain forward-looking elements regarding future events and results of the El.En. Group that are based on current expectations, estimates, and projections about the sector in which the Group operates, as well as on current management opinions. Such elements inherently carry a component of risk and uncertainty, as they depend on the occurrence of future events. It is highlighted that actual results may differ significantly from those announced due to a multitude of factors beyond the control of the Group, including global economic conditions, the impact of competition, and political and regulatory developments in Italy and abroad.
* * * * * *
El.En., an Italian company, is the parent of a high-tech industrial group operating in the optoelectronics sector. Based on proprietary technology and multidisciplinary know-how, the El.En. Group manufactures laser sources (gas, semiconductor, solid-state and liquid) and innovative laser systems for medical and industrial applications. The El.En. Group is the laser market leader in Italy and among the top operators in Europe. It designs, manufactures and sells worldwide:
- Medical laser equipment used in dermatology, cosmetics, physiotherapy, dentistry and gynecology;
- Industrial laser systems for applications ranging from cutting, marking and welding metals, wood, plastic and glass to decorating leather and textiles and restoring/conserving artwork;
- Laser systems for scientific research
ISIN code: IT0005453250 Acronym: ELN Traded on Euronext STAR Milan ("STAR") Mkt cap.: 0,9 B euros code : ELN.MI Bloomberg code: ELN IM
For more information:
El.En. S.p.A. Investor Relator Enrico ROMAGNOLI - [email protected] Tel. +39 055 8826807
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI - [email protected] Paolo SANTAGOSTINO - [email protected] Roberta MAZZEO – [email protected] Silvia MARONGIU - [email protected] Tel. +39 06-69923324

El.En. Group 2024 Income statement
(With reference to the attached financial statements, it should be noted that the audit has not yet been completed on December 31st, 2024).

| Income Statement | 31/12/2024 | Inc % | 31/12/2023 | Inc % | Var % |
|---|---|---|---|---|---|
| Revenues | 565.846 | 100,0% | 576.011 | 100,0% | -1,76% |
| Change in inventory of finished goods and WIP | 4.085 | 0,7% | 13.983 | 2,4% | -70,79% |
| Other revenues and income | 6.833 | 1,2% | 4.793 | 0,8% | 42,55% |
| Value of production | 576.763 | 101,9% | 594.788 | 103,3% | -3,03% |
| Purchase of raw materials | 267.172 | 47,2% | 313.900 | 54,5% | -14,89% |
| Change in inventory of raw material | 10.284 | 1,8% | (10.322) | -1,8% | |
| Other direct services | 53.669 | 9,5% | 56.441 | 9,8% | -4,91% |
| Gross margin | 245.637 | 43,4% | 234.769 | 40,8% | 4,63% |
| Other operating services and charges | 55.092 | 9,7% | 50.091 | 8,7% | 9,98% |
| Added value | 190.545 | 33,7% | 184.678 | 32,1% | 3,18% |
| Staff cost | 98.770 | 17,5% | 92.494 | 16,1% | 6,78% |
| EBITDA | 91.775 | 16,2% | 92.184 | 16,0% | -0,44% |
| Depreciation, amortization and other accruals | 13.467 | 2,4% | 13.965 | 2,4% | -3,57% |
| EBIT | 78.309 | 13,8% | 78.219 | 13,6% | 0,11% |
| Net financial income (charges) | 802 | 0,1% | (449) | -0,1% | |
| Share of profit of associated companies | 23 | 0,0% | 64 | 0,0% | -64,89% |
| Other net income and charges | 4.971 | 0,9% | 0 | 0,0% | |
| Income (loss) before taxes | 84.104 | 14,9% | 77.835 | 13,5% | 8,05% |
| Income taxes | 21.227 | 3,8% | 22.600 | 3,9% | -6,07% |
| Income (loss) from Continuing operations | 62.877 | 11,1% | 55.235 | 9,6% | 13,84% |
| Income (loss) from Discontinued operation | (10.372) | -1,8% | (5.169) | -0,9% | 100,67% |
| Income (loss) for the financial period | 52.505 | 9,3% | 50.067 | 8,7% | 4,87% |
| Net profit (loss) of minority interest | 892 | 0,2% | 1.827 | 0,3% | -51,20% |
| Net income (loss) | 51.613 | 9,1% | 48.239 | 8,4% | 6,99% |

| Statement of financial position | 31/12/2024 | 31/12/2023 | Variazione |
|---|---|---|---|
| Intangible assets | 4.692 | 4.162 | 529 |
| Tangible assets | 77.623 | 74.976 | 2.647 |
| Equity investments | 2.011 | 2.164 | (153) |
| Deferred tax assets | 11.299 | 10.910 | 390 |
| Other non-current assets | 7.612 | 24.092 | (16.481) |
| Total non current assets | 103.237 | 116.304 | (13.068) |
| Inventories | 172.394 | 180.371 | (7.978) |
| Accounts receivable | 117.982 | 127.689 | (9.707) |
| Tax receivables | 13.820 | 15.425 | (1.604) |
| Other receivables | 11.402 | 10.000 | 1.402 |
| Financial instruments | 10.017 | 4.315 | 5.702 |
| Cash and cash equivalents | 147.470 | 112.531 | 34.939 |
| Total current assets | 473.085 | 450.331 | 22.754 |
| Assets held for sale | 164.399 | 152.574 | 11.826 |
| Total Assets | 740.721 | 719.209 | 21.512 |
| Total shareholders' equity | 410.802 | 375.458 | 35.344 |
| Severance indemnity | 4.981 | 4.758 | 223 |
| Deferred tax liabilities | 2.973 | 2.970 | 2 |
| Reserve for risks and charges | 8.117 | 8.650 | (534) |
| Financial debts and liabilities | 23.498 | 27.199 | (3.701) |
| Other non current liabilities | 1.186 | 6.783 | (5.596) |
| Total non current liabilities | 40.755 | 50.360 | (9.605) |
| Financial liabilities | 23.246 | 23.517 | (270) |
| Accounts payable | 90.550 | 96.159 | (5.609) |
| Income tax payables | 3.667 | 4.344 | (677) |
| Other current payables | 53.227 | 55.428 | (2.201) |
| Total current liabilities | 170.690 | 179.448 | (8.757) |
| Liabilities directly associated with the assets held for sale | 118.474 | 113.944 | 4.530 |
| Total Liabilities and Shareholders' equity | 740.721 | 719.209 | 21.512 |

| Net financial position | 31/12/24 | 31/12/23 | |
|---|---|---|---|
| A | Cash and cash equivalents | 147.470 | 112.531 |
| B | Cash equivalents | ||
| C | Other current financial assets | 11.020 | 4.844 |
| D | Liquidity (A + B + C) | 158.490 | 117.375 |
| E | Current financial debt | (19.858) | (20.626) |
| F | Current portion of non-current financial debt | (3.389) | (2.890) |
| G | Current financial indebtedness (E + F) | (23.246) | (23.517) |
| H | Net current financial position (D + G) | 135.244 | 93.858 |
| I | Non-current financial debt | (13.500) | (17.379) |
| J | Debt instruments | (9.998) | (9.820) |
| K | Non-current trade and other payables | (1.186) | (6.783) |
| L | Non-current financial indebtedness (I + J + K) | (24.684) | (33.982) |
| M | Net Financial Position (H + L) | 110.559 | 59.877 |
| Cash flow statement | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Cash flow generated by operating activity | 76.889 | 12.816 |
| Cash flow generated by investing activity | 1.058 | (18.295) |
| Cash flow generated by financing activity | (35.501) | (18.631) |
| Change in cumulative translation adjustment reserve and other no monetary changes | (211) | (154) |
| Increase/(decrease) in asset available for sales | (7.296) | 7.193 |
| Increase/(decrease) in cash and cash equivalents | 34.939 | (17.071) |
| Cash and cash equivalents at the beginning of the financial period | 112.531 | 129.602 |
| Cash and cash equivalents at the end of the financial period | 147.470 | 112.531 |

| Income Statement | 31/12/2024 | Inc % | 31/12/2023 | Inc % | Var % |
|---|---|---|---|---|---|
| Revenues | 148.105 | 100,0% | 137.709 | 100,0% | 7,55% |
| Change in inventory of finished goods and WIP | 1.438 | 1,0% | (1.375) | -1,0% | |
| Other revenues and income | 1.251 | 0,8% | 2.114 | 1,5% | -40,83% |
| Value of production | 150.793 | 101,8% | 138.448 | 100,5% | 8,92% |
| Purchase of raw materials | 69.456 | 46,9% | 56.753 | 41,2% | 22,38% |
| Change in inventory of raw material | (1.515) | -1,0% | 3.968 | 2,9% | |
| Other direct services | 22.787 | 15,4% | 20.508 | 14,9% | 11,12% |
| Gross margin | 60.065 | 40,6% | 57.220 | 41,6% | 4,97% |
| Other operating services and charges | 9.562 | 6,5% | 10.112 | 7,3% | -5,44% |
| Added value | 50.504 | 34,1% | 47.109 | 34,2% | 7,21% |
| Staff cost | 26.875 | 18,1% | 24.368 | 17,7% | 10,29% |
| EBITDA | 23.628 | 16,0% | 22.741 | 16,5% | 3,90% |
| Depreciation, amortization and other accruals | 3.003 | 2,0% | 2.547 | 1,8% | 17,90% |
| EBIT | 20.625 | 13,9% | 20.193 | 14,7% | 2,14% |
| Net financial income (charges) | 17.115 | 11,6% | 13.612 | 9,9% | 25,73% |
| Share of profit of associated companies | 0 | 0 | |||
| Other net income and charges | (70) | 0,0% | 0 | ||
| Income (loss) before taxes | 37.670 | 25,4% | 33.805 | 24,5% | 11,43% |
| Income taxes | 3.682 | 2,5% | 5.683 | 4,1% | -35,22% |
| Income (loss) from Continuing operations | 33.988 | 22,9% | 28.122 | 20,4% | 20,86% |
| Income (loss) from Discontinued operation | 0 | 0 | |||
| Income (loss) for the financial period | 33.988 | 22,9% | 28.122 | 20,4% | 20,86% |
| Net profit (loss) of minority interest | 0 | 0 | |||
| Net income (loss) | 33.988 | 22,9% | 28.122 | 20,4% | 20,86% |

| Statement of financial position | 31/12/2024 | 31/12/2023 | Variazione |
|---|---|---|---|
| Intangible assets | 582 | 408 | 174 |
| Tangible assets | 19.643 | 19.945 | (302) |
| Equity investments | 24.067 | 23.060 | 1.007 |
| Deferred tax assets | 2.547 | 2.274 | 273 |
| Other non-current assets | 49.891 | 36.082 | 13.809 |
| Total non current assets | 96.729 | 81.769 | 14.961 |
| Inventories | 49.041 | 46.337 | 2.703 |
| Accounts receivable | 44.279 | 46.255 | (1.976) |
| Tax receivables | 6.460 | 5.694 | 766 |
| Other receivables | 4.607 | 6.357 | (1.751) |
| Financial instruments | 5.531 | - | 5.531 |
| Cash and cash equivalents | 43.694 | 32.970 | 10.724 |
| Total current assets | 153.611 | 137.614 | 15.998 |
| Assets held for sale | 1.167 | - | 1.167 |
| Total Assets | 251.507 | 219.382 | 32.125 |
| Total shareholders' equity | 208.273 | 186.966 | 21.307 |
| Severance indemnity | 609 | 634 | (26) |
| Deferred tax liabilities | 508 | 534 | (27) |
| Reserve for risks and charges | 916 | 851 | 65 |
| Financial debts and liabilities | 326 | 190 | 136 |
| Other non current liabilities | 339 | 730 | (391) |
| Total non current liabilities | 2.698 | 2.939 | (242) |
| Financial liabilities | 208 | 146 | 62 |
| Accounts payable | 28.287 | 15.589 | 12.698 |
| Income tax payables | - | - | - |
| Other current payables | 12.042 | 13.742 | (1.700) |
| Total current liabilities | 40.537 | 29.477 | 11.060 |
| Liabilities directly associated with the assets held for sale | - | - | - |
| Total Liabilities and Shareholders' equity | 251.507 | 219.382 | 32.125 |

| Net financial position | 31/12/24 | 31/12/23 | |
|---|---|---|---|
| A | Cash and cash equivalents | 43.694 | 32.970 |
| B | Cash equivalents | ||
| C | Other current financial assets | 6.245 | 270 |
| D | Liquidity (A + B + C) | 49.939 | 33.241 |
| E | Current financial debt | (6) | (3) |
| F | Current portion of non-current financial debt | (202) | (143) |
| G | Current financial indebtedness (E + F) | (208) | (146) |
| H | Net current financial position (D + G) | 49.732 | 33.095 |
| I | Non-current financial debt | ||
| J | Debt instruments | (326) | (190) |
| K | Non-current trade and other payables | (339) | (730) |
| L | Non-current financial indebtedness (I + J + K) | (666) | (920) |
| M | Net Financial Position (H + L) | 49.066 | 32.175 |
| Cash flow statement | 31/12/2024 | 31/12/2023 |
|---|---|---|
| Cash flow generated by operating activity | 46.730 | 31.816 |
| Cash flow generated by investing activity | (20.151) | (9.903) |
| Cash flow generated by financing activity | (15.855) | (17.477) |
| Change in cumulative translation adjustment reserve and other no monetary changes | - | 62 |
| Increase/(decrease) in cash and cash equivalents | 10.724 | 4.498 |
| Cash and cash equivalents at the beginning of the financial period | 32.970 | 28.472 |
| Cash and cash equivalents at the end of the financial period | 43.694 | 32.970 |


The El.En. Group uses some alternative performance measures which are not identified as accounting measures that are part of the IFRS in order to offer a better evaluation of the performance of the Group. Consequently, the criteria applied by the Group may not be homogeneous with that used by other companies and the results obtained may not be comparable with the results shown by these latter.
These alternative performance measures, determined in conformity with the guidelines for alternative measures issued by ESMA/2015/1415 and adopted by the CONSOB with notice nr. 92543 on December 3rd 2015, refer only to the economic performance of the period being considered and those with which it is being compared.
The Group uses the following alternative non-GAAP measures to evaluate the economic performance:
the value of production is determined by the sum of revenue, the change in inventory of finished goods and WIP and the other revenue and income;
the gross margin represents the indicator of the sales margin determined by adding to the Value Added the "Costs for operating services and charges".
the value added is determined by adding to the EBITDA the "cost for personnel";
the earnings before income taxes, devaluations, depreciations and amortizations or "EBITDA", also represents an indicator of operating performance and is determined by adding to the EBIT the amount of "Depreciations, Amortizations, accruals and devaluations";
the earnings before interest and income taxes, or "EBIT", represents the difference between revenue and other operating income and production costs, operating service and charges, depreciations, amortizations, accruals and devaluations;
the incidence that the various entries in the income statement have on the sales volume.
As alternative performance indicators to evaluate its capacity to meet their financial obligations, the Group uses:
| Fine Comunicato n.0481-26-2025 | Numero di Pagine: 21 |
|---|---|
| -------------------------------- | ---------------------- |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.